These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?
Why mutual funds are backing Lenskart’s ₹70,000 crore IPO despite steep valuation
The IPO, which opened on 31 October and closes on 4 November, comprises a fresh issue of ₹2,150 crore and an offer-for-sale of ₹5,128 crore. Lenskart raised ₹3,268 crore from 147 anchor investors ahead of the offer, including foreign institutions such as the Government of Singapore,
Read MoreBillionaire Warren Buffett's $184 Billion Warning to Wall Street Has Hit a Deafening Roar
The Oracle of Omaha has sold more stocks than he’s purchased for a staggering 12 consecutive quarters.
For the better part of the last six decades, Berkshire Hathaway‘s (BRK.A 0.50%)(BRK.B 0.39%) billionaire CEO Warren Buffett has made a habit of outperforming the benchmark S&P 500 (SNPINDEX: ^GSPC) on a total return basis,
Cathie Wood’s ARK Invest adds $12M in Bullish shares as options trading surges
Cathie Wood’s ARK Invest increased its position in Bullish crypto exchange on Monday, purchasing about 238,000 shares worth around $12 million across its flagship funds.
According to ARK’s daily trade disclosures, the ARK Innovation ETF (ARKK) bought 164,214 shares, the ARK Next Generation Internet ETF (ARKW) added 49,056 shares, and the ARK Fintech Innovation ETF (ARKF) acquired 25,076 shares.
» Read more about: Cathie Wood’s ARK Invest adds $12M in Bullish shares as options trading surges »
Read MoreThe Burst
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Ivy
Buffett’s $19 Billion Oil Bet Looks Like a Fortress
It’s the rare oil major that seems built to outlast cycles, keep the dividend flowing, and, as Warren Buffett clearly believes, keep getting stronger.
The yield is about 4.4%, nearly four times what the S&P 500 pays and on paper that looks tempting, but high yields in energy can be a trap. The difference here is Chevron’s payout isn’t balanced on a knife’s edge.
» Read more about: Buffett’s $19 Billion Oil Bet Looks Like a Fortress »
Read MoreThe Spotlight
2 Recession-Proof Stocks to Beat the 2025 Slowdown
While many economists and investors initially expected 2025 to be another good year, the outlook in America has soured rapidly as steep tariffs and a softer labor market appear set to increase prices and curtail growth.
Recently, JPMorgan Chase analysts raised their predicted recession risk for the year from 30% to 40% due largely to America’s emerging trade wars.
» Read more about: 2 Recession-Proof Stocks to Beat the 2025 Slowdown »